These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9205774

  • 21. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
    Tachikawa H, Kodama M, Hui L, Yoshida T, Hayashi M, Abe S, Kashimura T, Kato K, Hanawa H, Watanabe K, Nakazawa M, Aizawa Y.
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
    [Abstract] [Full Text] [Related]

  • 22. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
    Liang YH, Wang JM, Zhou Y, Jiang XJ, Jiang H, Huang CX.
    Life Sci; 2004 Aug 27; 75(15):1871-8. PubMed ID: 15302230
    [Abstract] [Full Text] [Related]

  • 23. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B, Oztürk M, Tunçdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E.
    Acta Histochem; 2002 Aug 27; 104(2):123-30. PubMed ID: 12086332
    [Abstract] [Full Text] [Related]

  • 24. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM, Palmisano M, Piraino A, Hirschhorn W, Spencer S, Prasad PP, Ortiz M, Lloyd P.
    Clin Pharmacol Ther; 1997 Jan 27; 61(1):35-44. PubMed ID: 9024172
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects.
    Latif F, Tandon S, Obeleniene R, Hankins SR, Berlowitz MS, Ennezat PV, Le Jemtel TH.
    J Card Fail; 2001 Sep 27; 7(3):265-8. PubMed ID: 11561228
    [Abstract] [Full Text] [Related]

  • 26. Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine.
    Ledingham JM, Phelan EL, Cross MA, Laverty R.
    J Vasc Res; 2000 Sep 27; 37(2):134-45. PubMed ID: 10754398
    [Abstract] [Full Text] [Related]

  • 27. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A, Finckenberg P, Korpi A, Loytainen M, Martonen E, Levijoki J, Mervaala E.
    J Physiol Pharmacol; 2011 Jun 27; 62(3):275-85. PubMed ID: 21893687
    [Abstract] [Full Text] [Related]

  • 28. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S.
    J Pharmacol Exp Ther; 2011 Nov 27; 339(2):358-66. PubMed ID: 21807884
    [Abstract] [Full Text] [Related]

  • 29. Enalapril and valsartan improve cyclosporine A-induced vascular dysfunction in spontaneously hypertensive rats.
    Lassila M, Finckenberg P, Pere AK, Vapaatalo H, Nurminen ML.
    Eur J Pharmacol; 2000 Jun 09; 398(1):99-106. PubMed ID: 10856453
    [Abstract] [Full Text] [Related]

  • 30. Role of angiotensin II type 2 receptor during regression of cardiac hypertrophy in spontaneously hypertensive rats.
    Der Sarkissian S, Tea BS, Touyz RM, deBlois D, Hale TM.
    J Am Soc Hypertens; 2013 Jun 09; 7(2):118-27. PubMed ID: 23414835
    [Abstract] [Full Text] [Related]

  • 31. Effects of chronic blockade of angiotensin II receptor on the maintenance of hypertension and vascular changes in spontaneously hypertensive rats.
    Gillies LK, Lee RM.
    Can J Physiol Pharmacol; 1996 Sep 09; 74(9):1061-9. PubMed ID: 8960399
    [Abstract] [Full Text] [Related]

  • 32. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug 09; 27(8):642-6. PubMed ID: 10901398
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T, Masuda J, Sutani T, Sakaguchi Y, Tsuchihashi M, Tsuruta S, Iwano M, Dohi K, Nakamura Y, Konishi N.
    Blood Press Suppl; 1994 Aug 09; 5():89-93. PubMed ID: 7889210
    [Abstract] [Full Text] [Related]

  • 34. Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats.
    Prieto I, Martínez JM, Hermoso F, Ramírez MJ, de Gasparo M, Vargas F, Alba F, Ramírez M.
    Horm Metab Res; 2001 Sep 09; 33(9):559-63. PubMed ID: 11561217
    [Abstract] [Full Text] [Related]

  • 35. Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.
    Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, Ma M, Nakagawa T, Waki H, Maeda M, Ogawa H, Kim-Mitsuyama S.
    Atherosclerosis; 2014 Sep 09; 236(1):101-7. PubMed ID: 25016364
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M, Matsumura S, Masui M, Matsuura E, Kawakami M, Fujitomo H, Umeda T, Kagawa H, Hirohata S, Shima K.
    Arzneimittelforschung; 1993 Dec 09; 43(12):1282-90. PubMed ID: 8141815
    [Abstract] [Full Text] [Related]

  • 37. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
    Chow L, De Gasparo M, Levens N.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):77-86. PubMed ID: 7498292
    [Abstract] [Full Text] [Related]

  • 38. Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).
    Webb RL, Navarrete AE, Davis S.
    Am J Hypertens; 1998 Jan 25; 11(1 Pt 1):59-65. PubMed ID: 9504451
    [Abstract] [Full Text] [Related]

  • 39. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP, Ennezat PV, Lisker J, Suryadevara V, Infeld J, Cukon S, Hammer A, Sonnenblick EH, Le Jemtel TH.
    Circulation; 2000 Feb 29; 101(8):844-6. PubMed ID: 10694521
    [Abstract] [Full Text] [Related]

  • 40. Decreased expression of angiotensin II type 1 and type 2 receptors in the brain after long-term administration of antihypertensive drugs in stroke-prone spontaneously hypertensive rat.
    Nishida Y, Takahashi Y, Sugahara-Kobayashi M, Ishikawa K, Asai S.
    J Pharmacol Sci; 2008 Apr 29; 106(4):663-6. PubMed ID: 18403896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.